Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
The Journal of Community and Supportive Oncology|February 10, 2016
Hospital readmission following transplantation: identifying risk factors and designing preventive measuresDorothy R McKenna, Matthew R Sullivan, John M Hill, et al.
Experimental Hematology|August 23, 2008
A cell stress signaling model of fetal hemoglobin induction: what doesn't kill red blood cells may make them strongerRodwell Mabaera, Rachel J West, Sarah J Conine, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2002
UBE1L is a retinoid target that triggers PML/RARalpha degradation and apoptosis in acute promyelocytic leukemiaSutisak Kitareewan, Ian Pitha-Rowe, David Sekula, et al.
Experimental Hematology|May 23, 2009
Developmentally regulated extended domains of DNA hypomethylation encompass highly transcribed genes of the human beta-globin locusMelissa J Lathrop, Mei Hsu, Christine A Richardson, et al.
Blood|July 20, 2006
Short-chain fatty acids induce gamma-globin gene expression by displacement of a HDAC3-NCoR repressor complexRishikesh Mankidy, Douglas V Faller, Rodwell Mabaera, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2020
Caregivers' Out-of-Pocket Expenses and Time Commitment Following Hematopoietic Stem Cell Transplantation at a Rural Cancer CenterKenneth R Meehan, John M Meehan, John M Hill, et al.
Blood Cells, Molecules & Diseases|June 7, 2011
Novel therapeutic candidates, identified by molecular modeling, induce γ-globin gene expression in vivoMichael S Boosalis, Serguei A Castaneda, Marie Trudel, et al.
Cancer Immunology Research|May 16, 2019
Hypoxia-Induced VISTA Promotes the Suppressive Function of Myeloid-Derived Suppressor Cells in the Tumor MicroenvironmentJie Deng, Jiannan Li, Aurelien Sarde, et al.
Blood Advances|February 10, 2025
Randomized phase 2 study to assess the role of single-agent nivolumab to maintain remission in acute myeloid leukemiaAthalia R Pyzer, Laura W Dillon, Elad Sharon, et al.
Pageof 3